MYC and neoplasm: Deletion of myeloid EP4 receptors led to markedly decreased adenoma ERK phosphorylation (Figure 2B), in association with inhibition of tumor cell proliferation, as indicated by significantly reduced expression levels of adenoma cyclin D1 and ki67 (Figure 2C) as well as c-Myc (Supplemental Figure S2B).